Stereotaxis (STXS) Share-based Compensation (2010 - 2026)
Stereotaxis (STXS) posted quarterly Share-based Compensation of $2.1 million for Q1 2026, down 16.77% year-over-year from $2.5 million in Q1 2025, and down 13.77% quarter-over-quarter from $2.4 million in Q4 2025.
Stereotaxis (STXS) Share-based Compensation (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Share-based Compensation for 17 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 16.77% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $6.6 million (down 7.71% YoY), while the FY2025 annual figure was $9.9 million, down 66.94% from the prior year.
- Share-based Compensation slipped to $2.1 million in Q1 2026 per STXS's latest filing, from $2.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $49.5 million in Q1 2022 and bottomed at -$496000.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $17.0 million across 5 years, with a median of $2.6 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 3510.5% — and 2024, when it plunged 118.82%.
- Stereotaxis' Share-based Compensation stood at $2.7 million in 2022, then decreased by 1.27% to $2.6 million in 2023, then tumbled by 118.82% to -$496000.0 in 2024, then surged by 593.35% to $2.4 million in 2025, then retreated by 13.77% to $2.1 million in 2026.
- Business Quant data shows STXS's Share-based Compensation at $2.1 million in Q1 2026, $2.4 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | -496,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Sep 30, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Dec 31, 2023 | 2.64 Mn |